VMI's second-quarter profit and revenues beat estimates. Full-year EPS outlook is up, factoring in the impacts of the realignment actions.

MTDR tops Q2 EPS estimates on record production and cost cuts despite lower oil prices and a revenue miss.

John Lovallo, UBS U.S. homebuilders analyst, joins CNBC's 'Squawk on the Street' to discuss outlooks on homebuilder earnings, expectations for when homebuyers will come off the sidelines, and more.

Healthcare Services Group, Inc. (NASDAQ:HCSG ) Q2 2025 Earnings Conference Call July 23, 2025 8:30 AM ET Company Participants Matthew J. McKee - Chief Communications Officer Theodore Wahl - President, CEO & Director Vikas Singh - Executive VP & CFO Conference Call Participants Albert J.

Trustmark Corporation (NASDAQ:TRMK ) Q2 2025 Earnings Call July 23, 2025 9:30 AM ET Company Participants Duane Arthur Dewey - President, CEO & Director F. Joseph Rein - Executive VP & Director of Corporate Strategy George T.

Ernest Hoffman is a Crypto and Market Reporter for Kitco News. He has over 15 years of experience as a writer, editor, broadcaster and producer for media, educational and cultural organizations.

GE Vernova (NYSE:GEV) shares surged almost 15% after the energy company's second quarter earnings beat expectations, driven by strong performance in its Power and Electrification segments. Earnings per share (EPS) of $1.86 were significantly ahead of estimates of $1.50.

Dream Finders Homes (DFH) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

MCO registers strong y/y earnings and revenue growth in Q2, though rising expenses and mixed segment results weigh.

Shares of Thermo Fisher Scientific Inc (NYSE:TMO, ETR:TN8) jumped nearly 12% on Wednesday morning after the company reported second-quarter results that topped Wall Street estimates, fueled by strong demand across its life sciences and diagnostics segments. The company posted revenue of $10.86 billion, surpassing analysts' expectations of $10.69 billion and marking a 3% year-over-year increase.

CPRX, STKL, GAMB and ORN are gaining attention as rising cash flows signal strength, flexibility and growth potential.

DARZALEX Faspro® is co-formulated with Halozyme's ENHANZE® drug delivery technology Approval represents critical advancement in early intervention for multiple myeloma SAN DIEGO , July 23, 2025 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) (Halozyme) today announced that Janssen-Cilag International NV, a Johnson & Johnson company, received European Commission (EC) approval of a new indication for DARZALEX Faspro® (daratumumab) co-formulated with ENHANZE®, as monotherapy for the treatment of adult patients with smouldering multiple myeloma (SMM) at high-risk of developing multiple myeloma. "This approval reinforces DARZALEX Faspro with ENHANZE as a foundational treatment across all stages of multiple myeloma," said Dr. Helen …

Most AI stocks at the moment are at nosebleed valuations.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Fortrea To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $50,000 in Fortrea between July 3, 2023 and February 28, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , July 23, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Fortrea Holdings Inc. ("Fortrea" …

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Petco To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $75,000 in Petco between January 14, 2021 and June 5, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , July 23, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Petco Health and Wellness …

T tops Q2 estimates with solid wireless growth, strong cash flow and momentum in fiber and 5G investments.

The headline numbers for First Community (FCCO) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

ATLANTA, July 23, 2025 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether Nutex Health Inc. (“Nutex” or the “Company”) (NASDAQ: NUTX) complied with federal securities laws. On July 22, 2025, Blue Orca Capital released a report regarding, among other things, Nutex's reimbursement rates. Following this news, the price of the Company's stock dropped.

The fintech company's disappointing growth trends in its merchant business have one analyst concerned that competition is dogging the Clover brand.

The Trump Administration policy of US energy independence, combined with the exponentially increased demands for electric power to fuel AI and data centers, is fueling increases in domestic oil and gas production due to the unreliability of wind and solar power.